In sensitivity analyses of excluded donors who met Reagan criteria for an AD neuropathological diagnosis, association sizes were larger for CTE stage, similar for dementia, and modestly reduced for measures of regional tau burden (Table 2, Figure 1, eTable 5 in the Supplement). The gene discussed is MAPT; the disease is dementia.